Streetbeat News

Stock Prices

Needham analyst Anna Andreeva reiterated a Buy rating on Wayfair Inc (NYSE:W) with a price target of $100. The analyst predicts continued top-line growth for Wayfair through 2024, despite pandemic gains being lapped. Wayfair's growth is expected to be driven by double-digit sales CAGR, international expansion, and a focus on advertising. The company's competitive edge in fulfillment through its own global logistics network is also seen as an under-appreciated asset.

Portfolio Pulse from Shivani Kumaresan

August 11, 2023 | 6:18 pm

CYBR

Stephens analyst Brian Colley has raised the price target on CyberArk Software Ltd. (NASDAQ:CYBR) from $180 to $210, maintaining an Overweight rating. This follows CyberArk's Q2 results, which showed a 61% rise in subscription revenue to $106.2 million. Despite a weak macro environment, CyberArk has seen resilient trends, with accelerating net new ARR growth and new customer wins. The company is also expanding its channel ecosystem, which has delivered key wins in the quarter. Following Q2, the analyst raised the FY2023/2024 revenue estimates and non-GAAP EPS estimates.

Portfolio Pulse from Nabaparna Bhattacharya

August 11, 2023 | 6:15 pm

TMO

Thermo Fisher Scientific's (NYSE:TMO) short percent of float has risen 11.27% since its last report, with 3.04 million shares sold short, which is 0.79% of all regular shares available for trading. This increase in short interest can signal that investors have become more bearish. However, compared to its peers, Thermo Fisher Scientific has less short interest as a percentage of float, which is 4.71% on average.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 6:15 pm

CPRT

Copart's (NYSE:CPRT) short percent of float has fallen 3.96% since its last report, with 4.18 million shares sold short, which is 0.97% of all regular shares available for trading. This decrease in short interest could indicate a more bullish market sentiment towards the stock. Copart's short interest as a percentage of float is less than its peer group average of 3.87%.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 6:15 pm

APTV

Aptiv's (NYSE:APTV) short percent of float has risen 10.78% since its last report, with 2.86 million shares sold short, which is 1.13% of all regular shares available for trading. This increase in short interest can act as an indicator of market sentiment towards a particular stock. However, compared to its peers, Aptiv has less short interest as a percentage of float, with an average of 5.86%.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 6:15 pm

ENTG

KLAC

MRVL

TER

TSM

Semiconductor and chip stocks are trading lower due to overall market weakness following July PPI data, which showed higher-than-expected inflation. The weakness may also be attributed to a pullback following this year's AI-driven momentum.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 6:12 pm

AMD

BABA

NVDA

QQQ

SPY

SSNLF

Nvidia Corp's stock is trading lower due to greater-than-expected inflation and overall market weakness. The stock is also affected by concerns over U.S.'s additional sanctions on China concerning artificial intelligence chips. Chinese companies, including Alibaba Group Holding, have ordered Nvidia AI chips in bulk, fearing a supply crisis. Concerns also loom over Nvidia's ability to supply AI chips, which could benefit Advanced Micro Devices, Inc and Samsung Electronics Co, Ltd.

Portfolio Pulse from Anusuya Lahiri

August 11, 2023 | 6:08 pm

SVV

Savers Value Village reported better-than-expected Q2 financial results and issued FY23 revenue guidance inline with estimates. Baird raised its price target from $27 to $28 on the stock, leading to a rise in the company's shares.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 6:07 pm

AREB

CTVA

LEO

MULN

During Friday's session, 157 stocks hit new 52-week lows. Among the notable companies were Corteva, American Rebel Holdings, Mullen Automotive, and BNY Mellon Strategic. The stocks that created new 52-week lows on Friday included Avangrid, SolarEdge Technologies, Etsy, UGI, Concentrix, Hawaiian Electric Indus, Equity Commonwealth, Forward Air, Cracker Barrel Old, Petco Health and Wellness, JinkoSolar Holding Co, Olaplex Hldgs, Frontier Group Holdings, Impinj, Safehold, Monro, 3D Sys, TDCX, Everbridge, Silk Road Medical, Cassava Sciences, 23andMe Holding, Wolverine World Wide, Avidity Biosciences, Boston Omaha, John Hancock Premium Div, BioLife Solns, Seres Therapeutics, American Well, Materialise, BNY Mellon Strategic, Southland Holdings, Funko, Fate Therapeutics, Citizens Financial Servs, American Lithium, Emergent BioSolutions, PetMed Express, Sutro Biopharma, Hippo Holdings, Largo, Omega Therapeutics, System1, Benson Hill, Eaton Vance Municipal, Vor Biopharma, Star Hldgs, Origin Mat, Joint, NanoString Technologies, Codexis, ContextLogic, Akoustis Technologies, Cano Health, GeneDx Hldgs, Electrovaya, Kezar Life Sciences, ProPhase Labs, Alaunos Therapeutics, Chimerix, Electriq Power Holdings, DZS, Streamline Health Solns, Eargo, Intercure, Prime Number Acquisition, REE Automotive, TD Hldgs, Carmell Therapeutics, Neuronetics, Kaixin Auto Hldgs, Crown Crafts, Airgain, Ohmyhome, Singular Genomics Sys, First Seacoast Bancorp, Sarcos Technology, Coya Therapeutics, Otonomo Technologies, CareCloud, Aterian, PAVmed, Orgenesis, CalAmp, Imperial Ptrl, Fitell, LQR House, Iridex, OMNIQ, Safeguard Scientifics, Lichen China, Origin Agritech, Atreca, Sunlight Finl Hldgs, Yunji, MediaCo Holding, Trio Petroleum, Cineverse, Lucy Scientific Discovery, Remark Hldgs, Shuttle Pharmaceuticals, Hempacco, Finch Therapeutics Gr, Visionary Education Tech, Marpai, Ontrak, Nogin, Adamis Pharmaceuticals, China Jo-Jo Drugstores, ABVC BioPharma, Fangdd Network Group, SeaStar Medical Holding, Yoshiharu Global, Universe Pharmaceuticals, Redhill Biopharma, Jiuzi Hldgs, Power REIT, Soligenix, Eightco Holdings, JanOne, Avalo Therapeutics, Yield10 Bioscience, Aditxt, Salarius Pharmaceuticals, China Pharma Holding, OpGen, Akanda, Harbor Custom Dev, Biocept, NeuBase Therapeutics, Ucommune International, INVO Bioscience, Esports Entertainment, American Rebel Holdings.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 6:01 pm

VVOS

Vivos Therapeutics (NASDAQ:VVOS) is set to release its latest quarterly earnings report on August 14, 2023. Analysts estimate an earnings per share (EPS) of $-0.14. The company's past performance shows a trend of missing EPS estimates and subsequent drops in share price. The stock is currently trading at $0.3431, down 76.23% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 6:01 pm